These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26637668)

  • 21. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways.
    Lee YS; Kim SY; Song SJ; Hong HK; Lee Y; Oh BY; Lee WY; Cho YB
    Oncotarget; 2016 Jun; 7(24):36842-36853. PubMed ID: 27167205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
    Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
    Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.
    Qu Y; Chen Q; Lai X; Zhu C; Chen C; Zhao X; Deng R; Xu M; Yuan H; Wang Y; Yu J; Huang J
    Mol Cancer; 2014 Apr; 13():95. PubMed ID: 24775912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
    Wilhelm SM; Carter C; Tang L; Wilkie D; McNabola A; Rong H; Chen C; Zhang X; Vincent P; McHugh M; Cao Y; Shujath J; Gawlak S; Eveleigh D; Rowley B; Liu L; Adnane L; Lynch M; Auclair D; Taylor I; Gedrich R; Voznesensky A; Riedl B; Post LE; Bollag G; Trail PA
    Cancer Res; 2004 Oct; 64(19):7099-109. PubMed ID: 15466206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the function and mechanism of long non-coding RNA DMTF1v4 in the occurrence of colon cancer.
    Zhuang ST; Cai YJ; Gao HC; Qiu JF; Zeng L; Zheng WJ
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3779-3788. PubMed ID: 29949153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway.
    Zhang X; Liu G; Ding L; Jiang T; Shao S; Gao Y; Lu Y
    J Cell Biochem; 2018 Mar; 119(3):2864-2874. PubMed ID: 29073728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling.
    Yang X; Zheng YT; Rong W
    Life Sci; 2019 Dec; 239():116916. PubMed ID: 31626792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the PI3K signaling pathway in KRAS mutant colon cancer.
    Hong S; Kim S; Kim HY; Kang M; Jang HH; Lee WS
    Cancer Med; 2016 Feb; 5(2):248-55. PubMed ID: 26715098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
    Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
    Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
    Cheng B; Rong A; Zhou Q; Li W
    J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Garcinone C suppresses colon tumorigenesis through the Gli1-dependent hedgehog signaling pathway.
    Chen J; Qiu S; Kim JT; Cho JS; Moon JH; Zhou Y; Auh JH; Lee HJ
    Phytomedicine; 2020 Dec; 79():153334. PubMed ID: 32920288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.
    Xue Z; Vis DJ; Bruna A; Sustic T; van Wageningen S; Batra AS; Rueda OM; Bosdriesz E; Caldas C; Wessels LFA; Bernards R
    Cell Res; 2018 Jul; 28(7):719-729. PubMed ID: 29795445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IDH1 Mutation Promotes Tumorigenesis by Inhibiting JNK Activation and Apoptosis Induced by Serum Starvation.
    Jiang B; Zhang J; Xia J; Zhao W; Wu Y; Shi M; Luo L; Zhou H; Chen A; Ma H; Zhao Q; Suleman M; Lin F; Zhou L; Wang J; Zhang Y; He Y; Li X; Hung LM; Mak TW; Li Q
    Cell Rep; 2017 Apr; 19(2):389-400. PubMed ID: 28402860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
    Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindin serves as a tumour suppressor gene during colon cancer progression through MAPK/ERK signalling pathway in mice.
    Cheng XS; Huo YN; Fan YY; Xiao CX; Ouyang XM; Liang LY; Lin Y; Wu JF; Ren JL; Guleng B
    J Cell Mol Med; 2020 Aug; 24(15):8391-8404. PubMed ID: 32614521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation.
    Hundley TR; Rigas B
    J Pharmacol Exp Ther; 2006 Jan; 316(1):25-34. PubMed ID: 16169935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.